Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 17:16:1083-1090.
doi: 10.1016/j.dib.2017.10.033. eCollection 2018 Feb.

Characterization of the transient middle cerebral artery occlusion model of ischemic stroke in a HuR transgenic mouse line

Affiliations

Characterization of the transient middle cerebral artery occlusion model of ischemic stroke in a HuR transgenic mouse line

A Ardelt et al. Data Brief. .

Abstract

This set of experiments characterizes a model of transient cerebral ischemic stroke in a transgenic (Tg) mouse line in which the glial fibrillary acidic protein (GFAP) promoter is utilized to drive expression of a human RNA-binding protein, HuR. Additionally, the effect of cerebral ischemia on the expression of endogenous Hu proteins is presented.

PubMed Disclaimer

Figures

Fig. 2
Fig. 2
Histology in Tg mice. (A) Neuropil rarefaction (asterisk). 1.25x; scale bar = 1 cm. (B) Red neurons (arrows) and neuropil vacuolation (asterisk). 20x; scale bar = 50 μm. (C) Hippocampal (arrows) and cortical (arrowheads) infarcts. 10x; scale bar = 500 μm. (D) High-power image of hippocampal injury. 60x; scale bar = 50 μm. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).
Fig. 3
Fig. 3
Distribution of endogenous Hu proteins in Wt mice 24 hours after injury. (A) Hu immunoreactivity (green) with nuclear and cytoplasmic distribution (arrow) in contralateral ROIs. (B) Decrease in Hu immunoreactivity (arrow) and Map2 immunofluorescence in the infarct borderzone. (C) Lack of Map2 signal and predominantly cytoplasmic Hu immunoreactivity (arrow) in the infarct core. (D) HuR/tubulin Western blot with densitometry, HuR normalized to tubulin, n = 6, mean ± SEM, *p = 0.046 (Student’s t-test). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
Fig. 4
Fig. 4
The effect of ischemia-reperfusion on Hu immunoreactivity in rats. Approximate locations of the images are demonstrated with asterisks in the diagrams: the stippled border represents the infarct borderzone. Top row: KSRP immunoreactivity in uninjured contralateral region (left column); periphery of injury, i.e., the region immediately adjacent to where KSRP immunoreactivity transitions to the altered pattern (middle column); and core of injury (right column). Middle row: Hu immunoreactivity in the same regions. Bottom row: merge of KSRP and Hu immunoreactivity, and Hoechst nuclear stain. In the contralateral region, there is colocalization of nuclear KSRP and Hu immunoreactivity in nuclei of most cells. Hu immunoreactivity is also cytoplasmic in some of the cells. On the ipsilateral side, at the periphery of injury, KSRP immunoreactivity attenuation appears greater than Hu immunoreactivity attenuation. In the core of injury, KSRP immunoreactivity is absent, and Hu immunoreactivity is located in the cytoplasm and processes of shrunken cells with preserved nuclei. Scale bar = 100 μm. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).
Fig. 1
Fig. 1
Reference diagram: infarct core (blue) and borderzone (yellow) and approximate locations of ipsilateral (Ipsi) and contralateral (Contra) ROI (grey boxes), not to scale. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.).

References

    1. Ardelt A.A., McCullough L.D., Korach K.S., Wang M.M., Munzenmaier D.H., Hurn P.D. Estradiol regulates angiopoietin-1 mRNA expression through estrogen receptor-alpha in a rodent experimental stroke model. Stroke; J. Cereb. Circ. 2005;36:337–341. - PubMed
    1. Carpenter R.S., Iwuchukwu I., Hinkson C.L., Reitz S., Lee W., Kukino A., Zhang A., Pike M.M., Ardelt A.A. High-dose estrogen treatment at reperfusion reduces lesion volume and accelerates recovery of sensorimotor function after experimental ischemic stroke. Brain Res. 1639;2016:200–213. - PMC - PubMed
    1. Hall M.P., Huang S., Black D.L. Differentiation-induced colocalization of the KH-type splicing regulatory protein with polypyrimidine tract binding protein and the c-src pre-mRNA. Mol. Biol. Cell. 2004;15:774–786. - PMC - PubMed
    1. Wheeler C., Nabors L.B., Barnum S., Yang X., Hu X., Schoeb T.R., Chen D., Ardelt A.A., King P.H. Sex hormone-dependent attenuation of EAE in a transgenic mouse with astrocytic expression of the RNA regulator HuR. J. Neuroimmunol. 2012;246:34–37. - PMC - PubMed